Published in Bull Med Libr Assoc on July 01, 1976
The contribution of hospital library information services to clinical care: a study in eight hospitals. Bull Med Libr Assoc (1987) 6.51
Clinical medical librarianship: a review of the literature. Bull Med Libr Assoc (1985) 4.83
Evaluation of a clinical medical librarian program at the Yale Medical Library. Bull Med Libr Assoc (1978) 2.41
Evolution of a mature clinical informationist model. J Am Med Inform Assoc (2005) 2.17
Quality filtering of the clinical literature by librarians and physicians. Bull Med Libr Assoc (1993) 1.87
Clinical medical librarian: the last unicorn? Bull Med Libr Assoc (1991) 1.66
The clinical librarian and the patient: report of a project at McMaster University Medical Centre. Bull Med Libr Assoc (1978) 1.61
Medical school graduates' retrospective evaluation of a clinical medical librarian program. Bull Med Libr Assoc (1979) 1.61
Information needs of clinicians: observations from a CML program. Bull Med Libr Assoc (1979) 1.50
Clinical medical librarians: what they do and why. Bull Med Libr Assoc (1978) 1.47
Clinical librarianship. Bull Med Libr Assoc (2000) 1.30
A modified clinical medical librarian program for the community hospital. Bull Med Libr Assoc (1980) 1.04
Clinical information coordinator: a new information specialist role for medical librarians. Bull Med Libr Assoc (1980) 1.03
Continuing education and library services for physicians in office practice. Bull Med Libr Assoc (1979) 0.96
A clinical reference program in the Department of Medicine, Tufts-New England Medical Center Hospital. Bull Med Libr Assoc (1978) 0.82
The effect of a clinical medical librarian on in-patient care outcomes. J Med Libr Assoc (2013) 0.82
The impact of medical libraries and literature on patient care in New Zealand. Bull Med Libr Assoc (1995) 0.81
The Jeremiah Metzger lecture. Information transfer in the service of Medicine. Trans Am Clin Climatol Assoc (1977) 0.75
A clinical information consultation service at a teaching hospital. Bull Med Libr Assoc (1983) 0.75
Biomedical librarians in a patient care setting at the University of Missouri-Kansas City School of Medicine. Bull Med Libr Assoc (1974) 10.88
Clinical medical librarians in a private teaching-hospital setting. Bull Med Libr Assoc (1975) 4.40
The effects of an information specialist on patient care and medical education. J Med Educ (1975) 3.77
Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J (1993) 3.75
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J (2005) 2.48
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med (1997) 2.25
Submental intubation: a literature review. Int J Oral Maxillofac Surg (2011) 2.21
Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax (1999) 1.94
Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid. Surg Gynecol Obstet (1972) 1.79
Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells (1997) 1.78
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Gastric Neurectomy for Gastric and Duodenal Ulceration : An Anatomic and Clinical Study. Ann Surg (1947) 1.71
Measurement of the energy spectrum of cosmic-ray induced neutrons aboard an ER-2 high-altitude airplane. Nucl Instrum Methods Phys Res A (2002) 1.64
An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med (1999) 1.51
Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax (2007) 1.50
The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis (1991) 1.49
Natural transfer of viable microbes in space. Icarus (2000) 1.45
Challenges in pulmonary fibrosis: 7--Novel therapies and lung transplantation. Thorax (2008) 1.40
Cystotomy closure. A comparison of the strength of appositional and inverting suture patterns. Vet Surg (1990) 1.40
Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses. Br J Dermatol (2014) 1.40
Histologic evaluation of response to implantation of polyvinilidine plates in dogs and rats. Vet Surg (1989) 1.39
Space radiation cancer risks and uncertainties for Mars missions. Radiat Res (2001) 1.33
Development of B-lymphocyte colony-forming cells in foetal mouse tissues. Immunology (1976) 1.22
Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J (1992) 1.20
The iron superoxide dismutase of Legionella pneumophila is essential for viability. J Bacteriol (1994) 1.18
Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med (1979) 1.15
The nature of the cells generating B-lymphocyte colonies in vitro. J Cell Physiol (1976) 1.14
Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol (1999) 1.14
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res (1999) 1.12
Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. J Thorac Cardiovasc Surg (1973) 1.11
Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc Natl Acad Sci U S A (1998) 1.09
Pulmonary microcirculatory response to shock, transfusion, and pump-oxygenator procedures: a unified mechanism underlying pulmonary damage. Surgery (1968) 1.09
Taxol: a history of pharmaceutical development and current pharmaceutical concerns. J Natl Cancer Inst Monogr (1993) 1.07
Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy. Can J Surg (1982) 1.07
Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol (1994) 1.06
Unusual acid-fast bacteria in panniculitis. Arch Dermatol (1966) 1.06
Accurate universal parameterization of absorption cross sections III--light systems. Nucl Instrum Methods Phys Res B (1999) 1.06
The lung in hemorrhagic shock. II. Observations on alveolar and vascular ultrastructure. Am J Pathol (1970) 1.05
A Study of the Results, both Favorable and Unfavorable, of Section of the Vagus Nerves in the Treatment of Peptic Ulcer. Ann Surg (1947) 1.05
Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation. Br J Pharmacol (1997) 1.04
4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist. J Med Chem (1985) 1.03
Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol (1995) 1.03
The lung in hemorrhagic shock. I. In vivo observations of pulmonary microcirculation in cats. Am J Pathol (1970) 1.02
Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med (2001) 1.00
Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Respir Dis (1987) 1.00
Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc (2001) 0.98
Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia (2012) 0.98
In vivo modulation of CYP enzymes by quinidine and rifampin. Clin Pharmacol Ther (2000) 0.95
Volvulus of the sigmoid, with special reference to the role of ganglion deficiency as an etiological factor. Can J Surg (1967) 0.94
Accurate universal parameterization of absorption cross sections II--neutron absorption cross sections. Nucl Instrum Methods Phys Res B (1997) 0.94
Accurate universal parameterization of absorption cross sections. Nucl Instrum Methods Phys Res B (1996) 0.93
Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer. J Urol (1992) 0.93
Nonspecificity of published assays for chloramphenicol solutions. J Pharm Sci (1966) 0.93
Diffuse biarticular pigmented villonodular synovitis. Radiology (1969) 0.92
Radial distribution of electron spectra from high-energy ions. Radiat Environ Biophys (1998) 0.92
The position of regenerating cambia: auxin/sucrose ratio and the gradient induction hypothesis. Proc R Soc Lond B Biol Sci (1978) 0.92
Traumatic granuloma of the tongue. Head Neck Surg (1983) 0.92
Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality. Crit Care Med (2000) 0.90
A pattern of pulmonary vascular reactivity and its importance in the pathogenesis of postoperative and posttraumatic pulmonary insufficiency. J Trauma (1968) 0.90
Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum Immunol (1994) 0.90
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines. J Med Chem (1980) 0.89
Long-term follow-up of coronary angioplasty: the 1977-1981 National Heart, Lung, and Blood Institute registry. Eur Heart J (1989) 0.89
Clinical application of cerebrospinal fluid creatine phosphokinase determination. J Am Vet Med Assoc (1977) 0.89
Pteridines. XII. Structure--activity relationships of some pteridine diuretics. J Med Chem (1968) 0.89
Joseph Nash McDowell, M.D., parts II and III. Regist Ky Hist Soc (1970) 0.89
Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med (1985) 0.89
Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1. Mol Pharmacol (1999) 0.88
Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects. J Allergy Clin Immunol (1993) 0.88
Necrotizing myelopathy associated with renal cell carcinoma. Urology (1983) 0.88
Effects of corticosteroids on complement and the neutrophilic polymorphonuclear leukocyte. Transplant Proc (1975) 0.87
Interstitial radiotherapy for localized carcinoma of the prostate. Can J Surg (1983) 0.87
An autoantibody reactive with nuclei of polymorphonuclear neutrophils: a cell differentiation marker. Blood (1981) 0.87
Subacute pulmonary melioidosis in a temperate climate. Med J Aust (1987) 0.87
Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects. Arch Dermatol (1968) 0.87
Flash pulmonary oedema during anidulafungin administration. J Clin Pharm Ther (2011) 0.86
Clinical determinants of the 6-Minute Walk Test in bronchiectasis. Respir Med (2008) 0.86
HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol (1995) 0.86
Osseous metaplasia of the spinal dura mater in a Great Dane. J Am Vet Med Assoc (1975) 0.86
The lung in hemorrhagic shock. IV. The role of neutrophilic polymorphonuclear leukocytes. Am J Pathol (1971) 0.86
Microvascular and histologic effect of circumferential wire on appositional bone growth in immature dogs. J Orthop Res (1985) 0.86
Effect of circumferential bands on cortical vascularity and viability. J Orthop Res (1991) 0.86
Continuing education in cancer for the community physician: design and evaluation of a regional table of contents service. Bull Med Libr Assoc (1981) 0.86
The influence of surgery on the natural history of angiographically documented left ventricular aneurysm: the Coronary Artery Surgery Study. Circulation (1986) 0.86
Cor triatriatum with intact subdividing diaphragm and partial anomalous pulmonary venous connection to the proximal left atrial chamber (an unreported type). Pediatrics (1971) 0.86
Immunopathological changes in the airways of stable lung transplant recipients. Thorax (1997) 0.85
Interplanetary crew exposure estimates for the August 1972 and October 1989 solar particle events. Radiat Res (1991) 0.85
Resistance of cerclage to knot failure. J Am Vet Med Assoc (1985) 0.85
Tumor necrosis factor alpha modulates mitogenic responses of human cultured airway smooth muscle. Am J Respir Cell Mol Biol (1995) 0.85
Effects of mind-body therapies on symptom clusters during the menopausal transition. Climacteric (2013) 0.85
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J Med Chem (1982) 0.85
Regulation of airway wall remodeling: prospects for the development of novel antiasthma drugs. Adv Pharmacol (1995) 0.84
Development of adenocarcinoma in transverse colon conduit. Urology (1982) 0.84
New calculations of the atmospheric cosmic radiation field--results for neutron spectra. Radiat Prot Dosimetry (2004) 0.84
Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J Urol (1985) 0.83
Immunoallergic aspects of coccidioidomycosis. Int J Dermatol (1971) 0.83
Effects of blood contamination on cerebrospinal fluid analysis. J Am Vet Med Assoc (1977) 0.83
Biological effectiveness of high-energy protons: target fragmentation. Radiat Res (1991) 0.83
Radiation risk and human space exploration. Adv Space Res (2003) 0.82
Effect of inhaled platelet-activating factor on bronchial inflammation in atopic non-asthmatic subjects. Int Arch Allergy Immunol (1992) 0.82
The encephalomyocarditis virus 3C protease is a substrate for the ubiquitin-mediated proteolytic system. J Biol Chem (1994) 0.82